Deerfield is a long term investor in healthcare companies and pharmaceuticals, including academic research partnerships on which Paul Hastings the CEO advised with Columbia University, Harvard University and UNC-Chapel Hill among others.
Special purpose acquisition company, Healthcare Acquisitions Corporation backed by Deerfield Management Company, has entered into a binding agreement for a business merger with AdaptHealth Holdings. Which is the third largest distributor of home medical equipment in the United States.
SPAC Stock DFHTU Agreement key Points
- The combined company will have an enterprise value of approximately $1.0 billion
- Blank check company Deerfield Healthcare Acquisition Corp. DFHTU has filed a preliminary prospectus for a $144M IPO of 12.5M Shares at $10 per share.
- Each unit will consist of one share of Class A common stock and 1/4th of a five year warrant to purchase one Class A share at $11.50.
SPAC Stock DFHTU or Deerfield Healthcare Technology Acquisitions Corp. Announced today the pricing of its initial public offering of 12,500,000 shares priced at 10$ per share. Deerfield will be listed on The NASDAQ and trade under the ticker symbol “DFHTU” beginning on July 17, 2020. Each unit consists of one share of Class A common stock and one fifth of one redeemable warrant.
Is SPAC Stock DFHTU A Buy
With the current pandemic that is shocking the market, it is likely there will be a lot of attention around the healthcare space especially for traders. With much currently unknown about the merger your betting on the management team as long term investment.